Previous close | 43.28 |
Open | 29.20 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 175.00 |
Expiry date | 2024-05-17 |
Day's range | 28.00 - 43.28 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.